iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
16 August 2023 - 1:30PM
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”),
an online global marketplace that connects scientists requiring
biospecimens for medical research with a network of healthcare
specimen providers, today announced that the Company has enhanced
its proprietary Marketplace platform to streamline biospecimen
matchmaking for researchers and providers. The platform’s new
capabilities enable iSpecimen’s Marketplace to efficiently collect
and store the most up-to-date data from providers for fulfilling
researcher orders at a lower cost. Over 30 unique data points will
be collected and tracked, including specimen availability,
accessible patient populations, storage and shipping access, viral
and genetic testing capabilities and more.
“iSpecimen’s goal is to quickly give researchers
access to the precise samples that they need to advance their
work,” said Tracy Curley, iSpecimen’s CEO. “Our Marketplace’s new
capabilities will expand the breadth of specimen types that the
platform provides by retrieving the most up-to-date information on
biospecimen and collection capabilities from providers in our
network. As matching biospecimen supply to research demand is the
foundation of our business, we are committed to continuing to
improve our technology to become an even better partner to
researchers and providers.”
iSpecimen’s enhanced Marketplace will also help
to increase providers’ return on investment by optimizing
workflows, enabling better communication, maximizing laboratory
potential, and reducing provider fatigue that can result from poor
matchmaking abilities.
“As the go-to online Marketplace for researchers
in need of biospecimens, iSpecimen is laser-focused on delivering
seamless matchmaking between researchers and providers at all
times,” added Evan Cox, iSpecimen’s Vice President, Head of Product
Management. “We are a technology-driven business that streamlines
the specimen procurement process using an online Marketplace
platform, rather than freezer banks. These new capabilities allow
us to maximize the inventory of our robust global provider network
to benefit researchers around the world.”
About iSpecimeniSpecimen
(Nasdaq: ISPC) offers an online marketplace for human biospecimens,
connecting scientists in commercial and non-profit organizations
with healthcare providers that have access to patients and
specimens needed for medical discovery. Proprietary, cloud-based
technology enables scientists to intuitively search for specimens
and patients across a federated partner network of hospitals, labs,
biobanks, blood centers and other healthcare organizations. For
more information, please visit www.ispecimen.com.
Forward-Looking Statements
This press release may contain forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Such forward-looking statements are
characterized by future or conditional verbs such as "may," "will,"
"expect," "intend," "anticipate," “believe," "estimate" and
"continue" or similar words. You should read statements that
contain these words carefully because they discuss future
expectations and plans, which contain projections of future results
of operations or financial condition or state other forward-looking
information.
Forward-looking statements are predictions,
projections and other statements about future events that are based
on current expectations and assumptions and, as a result, are
subject to risks and uncertainties. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this press release, including but not limited to the
risk factors contained in the Company's filings with the Securities
and Exchange Commission, which are available for review at
www.sec.gov. Forward-looking statements speak only as of the date
they are made. New risks and uncertainties arise over time, and it
is not possible for the Company to predict those events or how they
may affect the Company. If a change to the events and circumstances
reflected in the Company's forward-looking statements occurs, the
Company's business, financial condition and operating results may
vary materially from those expressed in the Company's
forward-looking statements.
Readers are cautioned not to put undue reliance
on forward-looking statements, and the Company assumes no
obligation and does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events or otherwise.
For further information, please
contact:
Investor ContactsKCSA Strategic
CommunicationsPhil Carlson / Erika Kay iSpecimen@kcsa.com
Media ContactsKCSA Strategic
CommunicationsRaquel Cona / Shana Marino iSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024